"V" . . . . "2010" . "RIV/00669806:_____/10:00300927" . "Niacin (kyselina nikotinov\u00E1) sni\u017Euje aterogenn\u00ED frakce a zvy\u0161uje protektivn\u00ED HDL-cholesterol. V kombinaci slaropiprantem m\u00E1 m\u00E9n\u011B ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F, p\u0159edev\u0161\u00EDm m\u00E9n\u011B flushingu." . "Fixn\u00ED kombinace niacin/laropiprant - renesance ve skupin\u011B hypolipidemik" . "Fixn\u00ED kombinace niacin/laropiprant - renesance ve skupin\u011B hypolipidemik" . "1"^^ . . . "1"^^ . . "Fixed combination niacin/laropiprant - revival of the use of a class of lipid-modifying drugs"@en . . . "Fixn\u00ED kombinace niacin/laropiprant - renesance ve skupin\u011B hypolipidemik"@cs . "Fixed combination niacin/laropiprant - revival of the use of a class of lipid-modifying drugs"@en . . "Remedia" . . "Fixn\u00ED kombinace niacin/laropiprant - renesance ve skupin\u011B hypolipidemik"@cs . "2"^^ . "niacin; nicotinic acid; laropiprant; lipid; modifying drugs"@en . "Rosolov\u00E1, Hana" . "259365" . "[B4D707334B01]" . . "RIV/00669806:_____/10:00300927!RIV11-MZ0-00669806" . . "CZ - \u010Cesk\u00E1 republika" . . . "Niacin (nicotinic acid) reduces aterogennic particles and increases protective HDL-cholesterol. The combination with laropiprant reduces side effects, especially flushing."@en . . . "2" . "Niacin (kyselina nikotinov\u00E1) sni\u017Euje aterogenn\u00ED frakce a zvy\u0161uje protektivn\u00ED HDL-cholesterol. V kombinaci slaropiprantem m\u00E1 m\u00E9n\u011B ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F, p\u0159edev\u0161\u00EDm m\u00E9n\u011B flushingu."@cs . "0862-8947" .